2018
DOI: 10.12688/f1000research.15480.1
|View full text |Cite
|
Sign up to set email alerts
|

Updates in Urologic Robot Assisted Surgery

Abstract: Modern robotics is an advanced minimally invasive technology with the advantages of wristed capability, three-dimensional optics, and tremor filtration compared with conventional laparoscopy. Urologists have been early adopters of robotic surgical technology: robotics have been used in urologic oncology for more than 20 years and there has been an increasing trend for utilization in benign urologic pathology in the last couple of years. The continuing development and interest in robotics are aimed at surgical … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
18
0

Year Published

2019
2019
2021
2021

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 40 publications
(18 citation statements)
references
References 40 publications
0
18
0
Order By: Relevance
“…Although many robotic surgical systems have been designed for MIS interventions, just a few of them are able to work on flexible ureteroscopy [44].…”
Section: State Of the Art A Surgical Robotsmentioning
confidence: 99%
“…Although many robotic surgical systems have been designed for MIS interventions, just a few of them are able to work on flexible ureteroscopy [44].…”
Section: State Of the Art A Surgical Robotsmentioning
confidence: 99%
“…Robotic-assisted surgery (RAS) is an example of high technology integration in health care, which has become ubiquitous in many surgical disciplines. RAS cases have tripled over the past decade [ 1 ] largely replacing both open and traditional laparoscopic surgeries for many common procedures [ 2 ]. Similar to many other types of technology in health care, RAS has changed tasks and workflow [ 3 , 4 ], demanding additional skills or training and introducing new complexities ranging from skill building and learning curves to workspace and organizational issues associated with operating room (OR) layout.…”
Section: Introductionmentioning
confidence: 99%
“…The newly developed renal clearable nanofluorophores [5] and organic dyes [2b] are mainly taking the glomerular filtration pathway and have been used for detecting kidney dysfunction [6] or improving positive contrast of many cancers [7] for fluorescence‐guided surgery. However, none of them was reported to selectively target primary kidney cancers over normal kidney tissues and “light up” the tumor margins with positive contrast (hyperfluorescence), which is highly demanded in fluorescence‐guided partial nephrectomy to preserve kidney function and improve the quality of life of patients with kidney cancer [8] (Scheme 1 d). Considering that over 90 percent of kidney cancer is renal cell carcinoma (RCC) originating from the renal tubular epithelial cell [9] (Scheme 1 c), the fundamental understanding of the interactions and transport of renal clearable dyes and nanoparticles with/in renal tubules is essential to designing new strategies for selectively targeting of RCC.…”
Section: Introductionmentioning
confidence: 99%
“…On the other hand, some other molecules can be actively excreted from peritubular capillaries into the lumen of the proximal tubules by utilizing the transporters on the basolateral side of proximal tubular cells,i nflux into the cells and efflux from the luminal side [4] (Scheme 1b). The newly developed renal clearable nanofluorophores [5] and organic dyes [2b] are mainly taking the glomerular filtration pathway and have been used for detecting kidney dysfunction [6] or improving positive contrast of many cancers [7] for fluorescence-guided surgery.H owever,n one of them was reported to selectively target primary kidney cancers over normal kidney tissues and "light up" the tumor margins with positive contrast (hyperfluorescence), which is highly demanded in fluorescence-guided partial nephrectomy to preserve kidney function and improve the quality of life of patients with kidney cancer [8] (Scheme 1d). Considering that over 90 percent of kidney cancer is renal cell carcinoma (RCC) originating from the renal tubular epithelial cell [9] (Scheme 1c), the fundamental understanding of the interactions and transport of renal clearable dyes and nanoparticles with/in renal tubules is essential to designing new strategies for selectively targeting of RCC.T he renal tubule-secretable fluorophores are particularly interesting because their enhanced interaction with basolateral side of renal tubules allows to fully investigate the correlation between renal transport of nanofluorophores and their ability of selective RCC targeting.…”
Section: Introductionmentioning
confidence: 99%